Lava Therapeutics B.V.
Hans van der Vliet is a professor medical oncology at the Amsterdam UMC, location VUmc. He received his MD from the University of Amsterdam in 1998 and his PhD (cum laude) and internal medicine specialization in medical oncology from the VU University in Amsterdam. He performed post-doctoral research at the Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School.
This person is not in any offices
Lava Therapeutics B.V.
Lava Therapeutics is focused on applying its expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy.